MEDP
Medpace Holdings, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #935
- Final score
- 19.94
- Years on list
- 3
↘ Down 78 since 2023
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- MEDP· Medpace Holdings, Inc.
- ROIV· Roivant Sciences Ltd.
- VKTX· Viking Therapeutics, Inc.
Figure 01 · Side-by-side summary
The headline numbers
ROIV
Roivant Sciences Ltd.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #917
- Final score
- 22.02
- Years on list
- 3
↘ Down 566 since 2023
VKTX
Viking Therapeutics, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #966
- Final score
- 15.78
- Years on list
- 2
↗ Climbed 8 since 2024
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | MEDP | ROIV | VKTX |
|---|---|---|---|
| Climate Change | 20.3 | 25.3 | 18.3 |
| Employee Relations | 25.4 | 31.5 | 14.5 |
| Environment | 9.8 | 15.0 | 10.9 |
| Stakeholders & Society | 12.8 | 20.6 | 19.3 |
| Human Rights | 23.2 | 4.1 | 6.3 |
| Governance | 24.7 | 26.2 | 15.7 |
| Performance Rating | 41.5 | 32.8 | 42.8 |